Therapeutic area
Immunology
Immune-mediated and autoimmune diseases.
Diseases
Atopic Dermatitis
$207.8B attributable cost
$23.2B drug spend
108 assets · 1 indication
Inflammatory Bowel Disease
$69.4B attributable cost
79 assets · 2 indications
Psoriasis
$87.4B attributable cost
69 assets · 1 indication
Psoriatic Arthritis
$27.1B attributable cost
$12.9B drug spend
18 assets · 1 indication
Rheumatoid Arthritis
$32.7B attributable cost
$13.4B drug spend
54 assets · 1 indication
Systemic Lupus Erythematosus
$4.5B attributable cost
$1.6B drug spend
47 assets · 1 indication